13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Review article: the management of heartburn in pregnancy.

      Alimentary Pharmacology & Therapeutics
      Antacids, adverse effects, therapeutic use, Anti-Ulcer Agents, Cisapride, Female, Gastroesophageal Reflux, drug therapy, therapy, Gastrointestinal Motility, drug effects, Heartburn, physiopathology, Histamine H2 Antagonists, Humans, Lactation, physiology, Metoclopramide, Pregnancy, Pregnancy Complications, Proton Pump Inhibitors, Sucralfate

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Heartburn is a normal consequence of pregnancy. The predominant aetiology is a decrease in lower oesophageal sphincter pressure caused by female sex hormones, especially progesterone. Serious reflux complications during pregnancy are rare; hence upper endoscopy and other diagnostic tests are infrequently needed. Gastro-oesophageal reflux disease during pregnancy should be managed with a step-up algorithm beginning with lifestyle modifications and dietary changes. Antacids or sucralfate are considered the first-line drug therapy. If symptoms persist, any of the histamine2-receptor antagonists can be used. Proton pump inhibitors are reserved for women with intractable symptoms or complicated reflux disease. All but omeprazole are FDA category B drugs during pregnancy. Most drugs are excreted in breast milk. Of systemic agents, only the histamine2-receptor antagonists, with the exception of nizatidine, are safe to use during lactation.

          Related collections

          Author and article information

          Comments

          Comment on this article